Cargando…

Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.

Detalles Bibliográficos
Autores principales:	Taylor, G. M., Harris, R., Freeman, C. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1975
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024885/ https://www.ncbi.nlm.nih.gov/pubmed/1061614

Ejemplares similares

Proceedings: Surface immunological markers in acute myeloblastic leukaemia.
por: Taylor, G. M., et al.
Publicado: (1975)

Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity.
por: Gale, D. G., et al.
Publicado: (1977)

Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
por: Taylor, G. M., et al.
Publicado: (1976)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

A Case of Acute Myeloblastic Leukæmia
por: Fleming, Robert A., et al.
Publicado: (1924)

Granulocyte function in myeloblastic leukaemia.
por: Wilkinson, P. M., et al.
Publicado: (1975)

Adiponectin in relation to childhood myeloblastic leukaemia
por: Petridou, E, et al.
Publicado: (2006)

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
por: Taylor, G. M., et al.
Publicado: (1976)

The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
por: Holmes, J. A., et al.
Publicado: (1994)

Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.
por: Tupchong, L., et al.
Publicado: (1978)

In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias.
por: Taylor, G. M.
Publicado: (1981)

Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.
por: Zhu, Y. M., et al.
Publicado: (1993)

Abnormal Chromatin Clumping in Myeloblasts Mimicking Chronic Lymphocytic Leukaemia: A Diagnostic Pitfall
por: Sehgal, Tushar, et al.
Publicado: (2021)

Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
por: Zuhrie, S. R., et al.
Publicado: (1980)

Cytomegalovirus keratitis in acute myeloblastic leukemia
por: Daryabari, Seyed-Hashem, et al.
Publicado: (2023)

Comparative effects of vinca alkaloids (VCR, VDS) and epipodophyllotoxin (VP16) on murine myeloblastic leukaemia.
por: Yamashita, Y., et al.
Publicado: (1987)

Effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on blast progenitors from acute myeloblastic leukaemia patients.
por: Nara, N., et al.
Publicado: (1987)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

The association between serum levels of oxLDL-lgG and oxLDL-lgM autoantibody with adult acute myeloblastic leukaemia
por: Li, Hao, et al.
Publicado: (2010)

Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France
por: Atsou, Kueshivi Midodji, et al.
Publicado: (2023)

STUDIES ON THE MATURATION OF MYELOBLASTS INTO MYELOCYTES AND ON AMITOTIC CELL DIVISION IN THE PERIPHERAL BLOOD IN SUBACUTE MYELOBLASTIC LEUCEMIA
por: Sabin, F. R., et al.
Publicado: (1924)

Acute acalculous cholecystitis complicating chemotherapy for acute myeloblastic leukemia
por: Kassar, Olfa, et al.
Publicado: (2015)

Expression of the p53 oncogene in acute myeloblastic leukemia
Publicado: (1986)

Actual biological diagnosis of acute myeloblastic leukemia in children
por: Buga Corbu, V, et al.
Publicado: (2014)

Medullary allotransplant in acute myeloblastic leukemia in a child
por: Buga Corbu, V, et al.
Publicado: (2014)

Proceedings: Clustering in acute childhood leukaemia in Dublin.
por: Fennelly, J. J., et al.
Publicado: (1975)

T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia
Publicado: (1986)

Proceedings: Methods for the study and cell differentiation in acute leukaemia.
por: Catovsky, D.
Publicado: (1975)

PB1868: COMPARISON OF MYELOBLAST CELL PERCENTAGE IN INVESTIGATIONS FOR ACUTE MYELOID LEUKAEMIA INCLUDING FLOW CYTOMETRY, BONE MARROW ASPIRATION AND BONE MARROW TREPHINE
por: Iftikhar, Naml
Publicado: (2023)

The CMC Concept and Test Experiment
por: Karlsson, B R
Publicado: (1994)

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
por: Chen, Yu-Jen, et al.
Publicado: (2016)

Proceedings: Triple chemotherapy in acute non-lymphocytic leukaemia.
por: Fennelly, J. J., et al.
Publicado: (1974)

PB1781: THERAPEUTIC POTENTIAL OF DNA DAMAGE RESPONSE IN ACUTE MYELOBLASTIC LEUKEMIA
por: Lapa, B., et al.
Publicado: (2022)

Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia in vitro.
por: Blatt, J., et al.
Publicado: (1984)

Modulation of Growth Factor Receptors on Acute Myeloblastic Leukemia Cells by Retinoic Acid
por: Tohda, Shuji, et al.
Publicado: (1994)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Assessment of Drug Sensitivity of Human Leukaemic Myeloblasts: I. Labelling Human Myeloblasts with (125)IUdR for Survival Studies in Mice
por: FalcãO, R. P., et al.
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_14g1904i944lffshgbcgidi301